Related Experiment Videos
Multiple myeloma biology: lessons from the 5TMM models
Karin Vanderkerken1, Kewal Asosingh, Peter Croucher
1Vrije Universiteit Brussel, Department of Hematology and Immunology, Brussels, Belgium. Karin.Vanderkerken@vub.ac.be
Immunological Reviews
|July 9, 2003
Summary
Murine 5TMM models effectively study multiple myeloma (MM) cell interactions and bone disease. Treatments targeting the bone marrow microenvironment, like OPG and bisphosphonates, show promise in reducing MM progression and improving survival.
Area of Science:
- Hematology
- Oncology
- Immunology
- Pharmacology
Background:
- Multiple myeloma (MM) is a B cell neoplasm involving plasma cell proliferation, osteolytic lesions, and angiogenesis.
- Three-dimensional interactions between humoral and cellular contacts are crucial in MM pathogenesis.
- The 5TMM murine models offer a platform to investigate these complex MM interactions.
Purpose of the Study:
- To review studies utilizing 5TMM models for understanding MM biology.
- To emphasize myeloma cell homing, clone characterization, and isotype switch variants.
- To evaluate therapeutic targets within the bone marrow microenvironment.
Main Methods:
- Utilized 5TMM murine models, involving in vivo transfer of myeloma cells.
- Investigated myeloma cell homing, migration, proliferation, and isotype switching.
- Administered osteoprotegerin (OPG) to block RANK/RANKL/OPG system and potent bisphosphonates.
Main Results:
- Treatments with OPG and bisphosphonates provided significant protection against myeloma-associated bone disease.
- Both therapeutic interventions decreased myeloma disease burden, indicated by lower tumor load.
- Enhanced survival of mice was observed following OPG and bisphosphonate treatments.
Conclusions:
- 5TMM models are powerful tools for unraveling basic MM biological processes.
- These models are effective for testing novel therapeutic targets for multiple myeloma.
- Targeting the bone marrow microenvironment shows significant therapeutic potential in MM.